Methyl 2-(5-Hydroxypyrimidin-2-Yl)Acetate
|
- $220 - $1197
- Product name: Methyl 2-(5-Hydroxypyrimidin-2-Yl)Acetate
- CAS: 948594-77-2
- MF: C7H8N2O3
- MW: 168.15
- EINECS:
- MDL Number:MFCD16987769
- Synonyms:Methyl 2-(5-Hydroxypyrimidin-2-Yl)Acetate;Methyl 2-(5-Hydroxypyrimidin-2-Yl)Acetate(WX649082);2-Pyrimidineacetic acid, 5-hydroxy-, methyl ester
5 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 25mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number5241AQ
- Product descriptionmethyl2-(5-hydroxypyrimidin-2-yl)acetate
- Packaging250mg
- Price$622.4
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number5241AQ
- Product descriptionmethyl2-(5-hydroxypyrimidin-2-yl)acetate
- Packaging1g
- Price$1193.6
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM323307
- Product descriptionMethyl2-(5-hydroxypyrimidin-2-yl)acetate 95%
- Packaging1g
- Price$1128
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11005610
- Product descriptionMethyl2-(5-hydroxypyrimidin-2-yl)acetate 95+%
- Packaging1g
- Price$1197
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB587800
- Product descriptionmethyl2-(5-hydroxypyrimidin-2-yl)acetate
- Packaging25mg
- Price$220
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 5241AQ | methyl2-(5-hydroxypyrimidin-2-yl)acetate | 250mg | $622.4 | 2021-12-16 | Buy |
| AK Scientific | 5241AQ | methyl2-(5-hydroxypyrimidin-2-yl)acetate | 1g | $1193.6 | 2021-12-16 | Buy |
| Chemenu | CM323307 | Methyl2-(5-hydroxypyrimidin-2-yl)acetate 95% | 1g | $1128 | 2021-12-16 | Buy |
| Crysdot | CD11005610 | Methyl2-(5-hydroxypyrimidin-2-yl)acetate 95+% | 1g | $1197 | 2021-12-16 | Buy |
| TRC | B587800 | methyl2-(5-hydroxypyrimidin-2-yl)acetate | 25mg | $220 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|